Interferon-Inducible GTPases in Host Resistance, Inflammation and Disease

Journal of Molecular Biology

Volumn 428, Issue 17, 2016, Pages 3495-3513

  Pilla Moffett, Danielle ^a   Barber, Matthew F ^b   Taylor, Gregory A ^c,d   Coers, Jörn ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; GBP; Inflammasome; IRG; IRGM

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; INFLAMMASOME; INTERFERON; INTERFERON INDUCIBLE GUANOSINE TRIPHOSPHATASE; MYXOVIRUS RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AUTOINFLAMMATORY DISEASE; BACTERIUM; CELL VACUOLE; CROHN DISEASE; EPITHELIUM CELL; GENE; GENE DUPLICATION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; INFLAMMATION; INNATE IMMUNITY; IRG GENE; MULTIGENE FAMILY; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTOZOON; REGULATORY MECHANISM; REVIEW; VIRUS; XENOPHAGY; ANIMAL; DISEASE RESISTANCE; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; VERTEBRATE; VIRUS INFECTION;

ANIMALS; DISEASE RESISTANCE; GTP PHOSPHOHYDROLASES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERONS; VERTEBRATES; VIRUS DISEASES; VIRUSES;

EID: 84969579633     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2016.04.032     Document Type: Review

References (141)

1. [1] Randow, F., MacMicking, J.D., James, L.C., Cellular self-defense: how cell-autonomous immunity protects against pathogens. Science 340 (2013), 701–706.
2. [2] Kawahara, T., Quinn, M.T., Lambeth, J.D., Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol. Biol., 7, 2007, 109.
3. [3] Borden, E.C., Sen, G.C., Uze, G., Silverman, R.H., Ransohoff, R.M., Foster, G.R., et al. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6 (2007), 975–990.
4. [4] Platanias, L.C., Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5 (2005), 375–386.
5. [5] Horisberger, M.A., Staeheli, P., Haller, O., Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl. Acad. Sci. U. S. A. 80 (1983), 1910–1914.
6. [6] Cheng, Y.S., Colonno, R.J., Yin, F.H., Interferon induction of fibroblast proteins with guanylate binding activity. J. Biol. Chem. 258 (1983), 7746–7750.
7. [7] Staeheli, P., Haller, O., Boll, W., Lindenmann, J., Weissmann, C., Mx protein: constitutive expression in 3 T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44 (1986), 147–158.
8. [8] Staeheli, P., Grob, R., Meier, E., Sutcliffe, J.G., Haller, O., Influenza virus-susceptible mice carry mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8 (1988), 4518–4523.
9. [9] Haller, O., Acklin, M., Staeheli, P., Influenza virus resistance of wild mice: wild-type and mutant mx alleles occur at comparable frequencies. J. Interf. Res. 7 (1987), 647–656.
10. [10] Lindenmann, J., Resistance of mice to mouse-adapted influenza A virus. Virology 16 (1962), 203–204.
11. [11] Taylor, G.A., Collazo, C.M., Yap, G.S., Nguyen, K., Gregorio, T.A., Taylor, L.S., et al. Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 751–755.
12. [12] Singh, S.B., Davis, A.S., Taylor, G.A., Deretic, V., Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313 (2006), 1438–1441.
13. [13] MacMicking, J.D., Taylor, G.A., McKinney, J.D., Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302 (2003), 654–659.
14. [14] Bernstein-Hanley, I., Coers, J., Balsara, Z.R., Taylor, G.A., Starnbach, M.N., Dietrich, W.F., The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 14,092–14,097.
15. [15] Parkes, M., Barrett, J.C., Prescott, N.J., Tremelling, M., Anderson, C.A., Fisher, S.A., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39 (2007), 830–832.
16. [16] Rioux, J.D., Xavier, R.J., Taylor, K.D., Silverberg, M.S., Goyette, P., Huett, A., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39 (2007), 596–604.
17. [17] Haller, O., Staeheli, P., Schwemmle, M., Kochs, G., Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23 (2015), 154–163.
18. [18] Holzinger, D., Jorns, C., Stertz, S., Boisson-Dupuis, S., Thimme, R., Weidmann, M., et al. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 81 (2007), 7776–7785.
19. [19] Arnheiter, H., Skuntz, S., Noteborn, M., Chang, S., Meier, E., Transgenic mice with intracellular immunity to influenza virus. Cell 62 (1990), 51–61.
20. [20] Pavlovic, J., Arzet, H.A., Hefti, H.P., Frese, M., Rost, D., Ernst, B., et al. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69 (1995), 4506–4510.
21. [21] Manz, B., Dornfeld, D., Gotz, V., Zell, R., Zimmermann, P., Haller, O., et al. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog., 9, 2013, e1003279.
22. [22] Kane, M., Yadav, S.S., Bitzegeio, J., Kutluay, S.B., Zang, T., Wilson, S.J., et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502 (2013), 563–566.
23. [23] Goujon, C., Moncorge, O., Bauby, H., Doyle, T., Ward, C.C., Schaller, T., et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502 (2013), 559–562.
24. [24] Liu, Z., Pan, Q., Ding, S., Qian, J., Xu, F., Zhou, J., et al. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14 (2013), 398–410.
25. [25] Mitchell, P.S., Young, J.M., Emerman, M., Malik, H.S., Evolutionary analyses suggest a function of MxB immunity proteins beyond Lentivirus restriction. PLoS Pathog., 11, 2015, e1005304.
26. [26] Mitchell, P.S., Emerman, M., Malik, H.S., An evolutionary perspective on the broad antiviral specificity of MxA. Curr. Opin. Microbiol. 16 (2013), 493–499.
27. [27] Gao, S., von der Malsburg, A., Dick, A., Faelber, K., Schroder, G.F., Haller, O., et al. Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. Immunity 35 (2011), 514–525.
28. [28] Gao, S., von der Malsburg, A., Paeschke, S., Behlke, J., Haller, O., Kochs, G., et al. Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature 465 (2010), 502–506.
29. [29] Pavlovic, J., Haller, O., Staeheli, P., Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66 (1992), 2564–2569.
30. [30] Krug, R.M., Shaw, M., Broni, B., Shapiro, G., Haller, O., Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J. Virol. 56 (1985), 201–206.
31. [31] Zurcher, T., Pavlovic, J., Staeheli, P., Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology 187 (1992), 796–800.
32. [32] Li, G., Zhang, J., Sun, Y., Wang, H., Wang, Y., The evolutionarily dynamic IFN-inducible GTPase proteins play conserved immune functions in vertebrates and cephalochordates. Mol. Biol. Evol. 26 (2009), 1619–1630.
33. [33] Bekpen, C., Hunn, J.P., Rohde, C., Parvanova, I., Guethlein, L., Dunn, D.M., et al. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol., 6, 2005, R92.
34. [34] Bekpen, C., Marques-Bonet, T., Alkan, C., Antonacci, F., Leogrande, M.B., Ventura, M., et al. Death and resurrection of the human IRGM gene. PLoS Genet., 5, 2009, e1000403.
35. [35] Daugherty, M.D., Malik, H.S., Rules of engagement: molecular insights from host-virus arms races. Annu. Rev. Genet. 46 (2012), 677–700.
36. [36] Behnke, M.S., Khan, A., Wootton, J.C., Dubey, J.P., Tang, K., Sibley, L.D., Virulence differences in toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 9631–9636.
37. [37] Reese, M.L., Zeiner, G.M., Saeij, J.P., Boothroyd, J.C., Boyle, J.P., Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 9625–9630.
38. [38] Lilue, J., Muller, U.B., Steinfeldt, T., Howard, J.C., Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse. Elife, 2, 2013, e01298.
39. [39] Hunn, J.P., Koenen-Waisman, S., Papic, N., Schroeder, N., Pawlowski, N., Lange, R., et al. Regulatory interactions between IRG resistance GTPases in the cellular response to Toxoplasma gondii. EMBO J. 27 (2008), 2495–2509.
40. [40] Coers, J., Bernstein-Hanley, I., Grotsky, D., Parvanova, I., Howard, J.C., Taylor, G.A., et al. Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J. Immunol. 180 (2008), 6237–6245.
41. [41] Haldar, A.K., Saka, H.A., Piro, A.S., Dunn, J.D., Henry, S.C., Taylor, G.A., et al. IRG and GBP host resistance factors target aberrant, “non-self” vacuoles characterized by the missing of “self” IRGM proteins. PLoS Pathog., 9, 2013, e1003414.
42. [42] Martens, S., Parvanova, I., Zerrahn, J., Griffiths, G., Schell, G., Reichmann, G., et al. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog., 1, 2005, e24.
43. [43] Coers, J., Self and non-self discrimination of intracellular membranes by the innate immune system. PLoS Pathog., 9, 2013, e1003538.
44. [44] Ferreira-da-Silva Mda, F., Springer-Frauenhoff, H.M., Bohne, W., Howard, J.C., Identification of the microsporidian Encephalitozoon cuniculi as a new target of the IFNgamma-inducible IRG resistance system. PLoS Pathog., 10, 2014, e1004449.
45. [45] Tiwari, S., Choi, H.P., Matsuzawa, T., Pypaert, M., MacMicking, J.D., Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria. Nat. Immunol. 10 (2009), 907–917.
46. [46] Springer, H.M., Schramm, M., Taylor, G.A., Howard, J.C., Irgm1 (LRG-47), a regulator of cell-autonomous immunity, does not localize to mycobacterial or listerial phagosomes in IFN-gamma-induced mouse cells. J. Immunol. 191 (2013), 1765–1774.
47. [47] Shibata, M., Yoshimura, K., Furuya, N., Koike, M., Ueno, T., Komatsu, M., et al. The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem. Biophys. Res. Commun. 382 (2009), 419–423.
48. [48] Choi, J., Park, S., Biering, S.B., Selleck, E., Liu, C.Y., Zhang, X., et al. The parasitophorous vacuole membrane of Toxoplasma gondii is targeted for disruption by ubiquitin-like conjugation systems of autophagy. Immunity 40 (2014), 924–935.
49. [49] Al-Zeer, M.A., Al-Younes, H.M., Braun, P.R., Zerrahn, J., Meyer, T.F., IFN-gamma-inducible Irga6 mediates host resistance against chlamydia trachomatis via autophagy. PLoS One, 4, 2009, e4588.
50. [50] Haldar, A.K., Piro, A.S., Pilla, D.M., Yamamoto, M., Coers, J., The E2-like conjugation enzyme Atg3 promotes binding of IRG and Gbp proteins to Chlamydia- and Toxoplasma-containing vacuoles and host resistance. PLoS One, 9, 2014, e86684.
51. [51] Ohshima, J., Lee, Y., Sasai, M., Saitoh, T., Su Ma, J., Kamiyama, N., et al. Role of mouse and human autophagy proteins in IFN-gamma-induced cell-autonomous responses against Toxoplasma gondii. J. Immunol. 192 (2014), 3328–3335.
52. [52] Haldar, A.K., Foltz, C., Finethy, R., Piro, A.S., Feeley, E.M., Pilla-Moffett, D.M., et al. Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E5628–E5637.
53. [53] Zhao, Y.O., Khaminets, A., Hunn, J.P., Howard, J.C., Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death. PLoS Pathog., 5, 2009, e1000288.
54. [54] Ling, Y.M., Shaw, M.H., Ayala, C., Coppens, I., Taylor, G.A., Ferguson, D.J., et al. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J. Exp. Med. 203 (2006), 2063–2071.
55. [55] Williams, M., Kim, K., From membranes to organelles: emerging roles for dynamin-like proteins in diverse cellular processes. Eur. J. Cell Biol. 93 (2014), 267–277.
56. [56] Yamamoto, M., Okuyama, M., Ma, J.S., Kimura, T., Kamiyama, N., Saiga, H., et al. A cluster of interferon-gamma-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity, 2012.
57. [57] Perry, L.L., Su, H., Feilzer, K., Messer, R., Hughes, S., Whitmire, W., et al. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J. Immunol. 162 (1999), 3541–3548.
58. [58] Bernstein-Hanley, I., Balsara, Z.R., Ulmer, W., Coers, J., Starnbach, M.N., Dietrich, W.F., Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun. 7 (2006), 122–129.
59. [59] Gazzinelli, R.T., Mendonca-Neto, R., Lilue, J., Howard, J., Sher, A., Innate resistance against Toxoplasma gondii: an evolutionary tale of mice, cats, and men. Cell Host Microbe 15 (2014), 132–138.
60. [60] Collazo, C.M., Yap, G.S., Sempowski, G.D., Lusby, K.C., Tessarollo, L., Woude, G.F., et al. Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J. Exp. Med. 194 (2001), 181–188.
61. [61] Khaminets, A., Hunn, J.P., Konen-Waisman, S., Zhao, Y.O., Preukschat, D., Coers, J., et al. Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell. Microbiol. 12 (2010), 939–961.
62. [62] Zhao, Y., Ferguson, D.J., Wilson, D.C., Howard, J.C., Sibley, L.D., Yap, G.S., Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J. Immunol. 182 (2009), 3775–3781.
63. [63] Niedelman, W., Gold, D.A., Rosowski, E.E., Sprokholt, J.K., Lim, D., Farid Arenas, A., et al. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog., 8, 2012, e1002784.
64. [64] Lim, D., Gold, D.A., Julien, L., Rosowski, E.E., Niedelman, W., Yaffe, M.B., et al. Structure of the Toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence. J. Biol. Chem. 288 (2013), 34968–34980.
65. [65] Fentress, S.J., Behnke, M.S., Dunay, I.R., Mashayekhi, M., Rommereim, L.M., Fox, B.A., et al. Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8 (2010), 484–495.
66. [66] Fleckenstein, M.C., Reese, M.L., Konen-Waisman, S., Boothroyd, J.C., Howard, J.C., Steinfeldt, T., A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLoS Biol., 10, 2012, e1001358.
67. [67] Steinfeldt, T., Konen-Waisman, S., Tong, L., Pawlowski, N., Lamkemeyer, T., Sibley, L.D., et al. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol., 8, 2010, e1000576.
68. [68] Chauhan, S., Mandell, M.A., Deretic, V., IRGM governs the core autophagy machinery to conduct antimicrobial defense. Mol. Cell 58 (2015), 507–521.
69. [69] Singh, S.B., Ornatowski, W., Vergne, I., Naylor, J., Delgado, M., Roberts, E., et al. Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nat. Cell Biol. 12 (2010), 1154–1165.
70. [70] Intemann, C.D., Thye, T., Niemann, S., Browne, E.N., Amanua Chinbuah, M., Enimil, A., et al. Autophagy gene variant IRGM -261 T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog.(5), 2009, e1000577.
71. [71] Lapaquette, P., Bringer, M.A., Darfeuille-Michaud, A., Defects in autophagy favour adherent-invasive Escherichia Coli persistence within macrophages leading to increased pro-inflammatory response. Cell. Microbiol. 14 (2012), 791–807.
72. [72] McCarroll, S.A., Huett, A., Kuballa, P., Chilewski, S.D., Landry, A., Goyette, P., et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet., 2008.
73. [73] Gutierrez, M.G., Master, S.S., Singh, S.B., Taylor, G.A., Colombo, M.I., Deretic, V., Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119 (2004), 753–766.
74. [74] Matsuzawa, T., Kim, B.H., Shenoy, A.R., Kamitani, S., Miyake, M., Macmicking, J.D., IFN-gamma elicits macrophage autophagy via the p38 MAPK signaling pathway. J. Immunol., 2012.
75. [75] Filomeni, G., De Zio, D., Cecconi, F., Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 22 (2015), 377–388.
76. [76] Liu, B., Gulati, A.S., Cantillana, V., Henry, S.C., Schmidt, E.A., Daniell, X., et al. Irgm1-deficient mice exhibit Paneth cell abnormalities and increased susceptibility to acute intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 305 (2013), G573–G584.
77. [77] Henry, S.C., Schmidt, E.A., Fessler, M.B., Taylor, G.A., Palmitoylation of the immunity related GTPase, Irgm1: impact on membrane localization and ability to promote mitochondrial fission. PLoS One, 9, 2014, e95021.
78. [78] Coers, J., Gondek, D.C., Olive, A.J., Rohlfing, A., Taylor, G.A., Starnbach, M.N., Compensatory T cell responses in IRG-deficient mice prevent sustained Chlamydia trachomatis infections. PLoS Pathog., 7, 2011, e1001346.
79. [79] Feng, C.G., Zheng, L., Jankovic, D., Bafica, A., Cannons, J.L., Watford, W.T., et al. The immunity-related GTPase Irgm1 promotes the expansion of activated CD4 + T cell populations by preventing interferon-gamma-induced cell death. Nat. Immunol. 9 (2008), 1279–1287.
80. [80] Henry, S.C., Daniell, X., Indaram, M., Whitesides, J.F., Sempowski, G.D., Howell, D., et al. Impaired macrophage function underscores susceptibility to Salmonella in mice lacking Irgm1 (LRG-47). J. Immunol. 179 (2007), 6963–6972.
81. [81] Henry, S.C., Daniell, X.G., Burroughs, A.R., Indaram, M., Howell, D.N., Coers, J., et al. Balance of Irgm protein activities determines IFN-gamma-induced host defense. J. Leukoc. Biol. 85 (2009), 877–885.
82. [82] Klamp, T., Boehm, U., Schenk, D., Pfeffer, K., Howard, J.C., A giant GTPase, very large inducible GTPase-1, is inducible by IFNs. J. Immunol. 171 (2003), 1255–1265.
83. [83] Gupta, S.L., Rubin, B.Y., Holmes, S.L., Interferon action: induction of specific proteins in mouse and human cells by homologous interferons. Proc. Natl. Acad. Sci. U. S. A. 76 (1979), 4817–4821.
84. [84] Praefcke, G.J., McMahon, H.T., The dynamin superfamily: universal membrane tubulation and fission molecules?. Nat. Rev. Mol. Cell Biol. 5 (2004), 133–147.
85. [85] Kresse, A., Konermann, C., Degrandi, D., Beuter-Gunia, C., Wuerthner, J., Pfeffer, K., et al. Analyses of murine GBP homology clusters based on in silico, in vitro, and in vivo studies. BMC Genomics, 9, 2008, 158.
86. [86] Cheng, Y.S., Patterson, C.E., Staeheli, P., Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol. Cell. Biol. 11 (1991), 4717–4725.
87. [87] Prakash, B., Praefcke, G.J., Renault, L., Wittinghofer, A., Herrmann, C., Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403 (2000), 567–571.
88. [88] Ghosh, A., Praefcke, G.J., Renault, L., Wittinghofer, A., Herrmann, C., How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP. Nature 440 (2006), 101–104.
89. [89] Olszewski, M.A., Gray, J., Vestal, D.J., In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. J. Interf. Cytokine Res. 26 (2006), 328–352.
90. [90] Guenzi, E., Topolt, K., Lubeseder-Martellato, C., Jorg, A., Naschberger, E., Benelli, R., et al. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J. 22 (2003), 3772–3782.
91. [91] Guenzi, E., Topolt, K., Cornali, E., Lubeseder-Martellato, C., Jorg, A., Matzen, K., et al. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 20 (2001), 5568–5577.
92. [92] Anderson, S.L., Carton, J.M., Lou, J., Xing, L., Rubin, B.Y., Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256 (1999), 8–14.
93. [93] Carter, C.C., Gorbacheva, V.Y., Vestal, D.J., Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Arch. Virol. 150 (2005), 1213–1220.
94. [94] Nordmann, A., Wixler, L., Boergeling, Y., Wixler, V., Ludwig, S., A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J. 26 (2012), 1290–1300.
95. [95] Krapp, C., Hotter, D., Gawanbacht, A., McLaren, P.J., Kluge, S.F., Sturzel, C.M., et al. Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity. Cell Host Microbe 19 (2016), 504–514.
96. [96] Degrandi, D., Konermann, C., Beuter-Gunia, C., Kresse, A., Wurthner, J., Kurig, S., et al. Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J. Immunol. 179 (2007), 7729–7740.
97. [97] Tietzel, I., El-Haibi, C., Carabeo, R.A., Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma. PLoS One, 4, 2009, e6499.
98. [98] Al-Zeer, M.A., Al-Younes, H.M., Lauster, D., Abu Lubad, M., Meyer, T.F., Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins. Autophagy 9 (2013), 50–62.
99. [99] Johnston, A.C., Piro, A., Clough, B., Siew, M., Virreira Winter, S., Coers, J., et al. Human GBP1 does not localise to pathogen vacuoles but restricts Toxoplasma gondii. Cell. Microbiol., 2016.
100. [100] Kim, B.H., Shenoy, A.R., Kumar, P., Das, R., Tiwari, S., MacMicking, J.D., A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Science 332 (2011), 717–721.
101. [101] Degrandi, D., Kravets, E., Konermann, C., Beuter-Gunia, C., Klumpers, V., Lahme, S., et al. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 294–299.
102. [102] Kravets, E., Degrandi, D., Ma, Q., Peulen, T.O., Klumpers, V., Felekyan, S., et al. Guanylate binding proteins (GBPs) directly attack via supramolecular complexes. Elife, 5, 2016.
103. [103] Selleck, E.M., Fentress, S.J., Beatty, W.L., Degrandi, D., Pfeffer, K., Virgin, H.W., et al. Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog., 9, 2013, e1003320.
104. [104] Vestal, D.J., Gorbacheva, V.Y., Sen, G.C., Different subcellular localizations for the related interferon-induced GTPases, MuGBP-1 and MuGBP-2: implications for different functions?. J. Interf. Cytokine Res. 20 (2000), 991–1000.
105. [105] Britzen-Laurent, N., Bauer, M., Berton, V., Fischer, N., Syguda, A., Reipschlager, S., et al. Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner. PLoS One, 5, 2010, e14246.
106. [106] Stickney, J.T., Buss, J.E., Murine guanylate-binding protein: incomplete geranylgeranyl isoprenoid modification of an interferon-gamma-inducible guanosine triphosphate-binding protein. Mol. Biol. Cell 11 (2000), 2191–2200.
107. [107] Virreira Winter, S., Niedelman, W., Jensen, K.D., Rosowski, E.E., Julien, L., Spooner, E., et al. Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it. PLoS One, 6, 2011, e24434.
108. [108] Kravets, E., Degrandi, D., Weidtkamp-Peters, S., Ries, B., Konermann, C., Felekyan, S., et al. The GTPase activity of murine guanylate-binding protein 2 (mGBP2) controls the intracellular localization and recruitment to the parasitophorous vacuole of Toxoplasma gondii. J. Biol. Chem. 287 (2012), 27452–27466.
109. [109] Ohshima, J., Sasai, M., Liu, J., Yamashita, K., Ma, J.S., Lee, Y., et al. RabGDIalpha is a negative regulator of interferon-gamma-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondii. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E4581–E4590.
110. [110] Traver, M.K., Henry, S.C., Cantillana, V., Oliver, T., Hunn, J.P., Howard, J.C., et al. Immunity-related gtpase M (IRGM) proteins influence the localization of guanylate-binding protein 2 (GBP2) by modulating macroautophagy. J. Biol. Chem., 2011.
111. [111] Roberts, R.L., Hollis-Moffatt, J.E., Gearry, R.B., Kennedy, M.A., Barclay, M.L., Merriman, T.R., Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun. 9 (2008), 561–565.
112. [112] Latiano, A., Palmieri, O., Cucchiara, S., Castro, M., D'Inca, R., Guariso, G., et al. Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am. J. Gastroenterol. 104 (2009), 110–116.
113. [113] Sehgal, R., Berg, A., Polinski, J.I., Hegarty, J.P., Lin, Z., McKenna, K.J., et al. Mutations in IRGM are associated with more frequent need for surgery in patients with ileocolonic Crohn's disease. Dis. Colon & Rectum 55 (2012), 115–121.
114. [114] Fisher, S.A., Tremelling, M., Anderson, C.A., Gwilliam, R., Bumpstead, S., Prescott, N.J., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat. Genet. 40 (2008), 710–712.
115. [115] Franke, A., Balschun, T., Karlsen, T.H., Hedderich, J., May, S., Lu, T., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat. Genet. 40 (2008), 713–715.
116. [116] Weersma, R.K., Stokkers, P.C.F., Cleynen, I., Wolfkamp, S.C.S., Henckaerts, L., Schreiber, S., et al. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch–Belgian cohort. Am. J. Gastroenterol. 104 (2009), 630–638.
117. [117] Palomino-Morales, R.J., Oliver, J., Gomez-Garcia, M., Lopez-Nevot, M.A., Rodrigo, L., Nieto, A., et al. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun. 10 (2009), 356–364.
118. [118] Li, Y., Feng, S.T., Yao, Y., Yang, L., Xing, Y., Wang, Y., et al. Correlation between IRGM genetic polymorphisms and Crohn's disease risk: a meta-analysis of case-control studies. Genet. Mol. Res. 13 (2014), 10,741–10,753.
119. [119] McCarroll, S.A., Huett, A., Kuballa, P., Chilewski, S.D., Landry, A., Goyette, P., et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet. 40 (2008), 1107–1112.
120. [120] Bekpen, C., Xavier, R.J., Eichler, E.E., Human IRGM gene “to be or not to be”. Semin. Immunopathol. 32 (2010), 437–444.
121. [121] Brest, P., Lapaquette, P., Souidi, M., Lebrigand, K., Cesaro, A., Vouret-Craviari, V., et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat. Genet. 43 (2011), 242–245.
122. [122] Wirtz, S., Neufert, C., Weigmann, B., Neurath, M.F., Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2 (2007), 541–546.
123. [123] Sorace, J.M., Johnson, R.J., Howard, D.L., Drysdale, B.E., Identification of an endotoxin and IFN-inducible cDNA: possible identification of a novel protein family. J. Leukoc. Biol. 58 (1995), 477–484.
124. [124] Cadwell, K., Patel, K.K., Komatsu, M., Virgin, H.W., Stappenbeck, T.S., A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease. Autophagy 5 (2009), 250–252.
125. [125] Cadwell, K., Liu, J.Y., Brown, S.L., Miyoshi, H., Loh, J., Lennerz, J.K., et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456 (2008), 259–263.
126. [126] Saitoh, T., Fujita, N., Jang, M.H., Uematsu, S., Yang, B.G., Satoh, T., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456 (2008), 264–268.
127. [127] Cadwell, K., Patel, K.K., Maloney, N.S., Liu, T.C., Ng, A.C., Storer, C.E., et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141 (2010), 1135–1145.
128. [128] Rupper, A.C., Cardelli, J.A., Induction of guanylate binding protein 5 by gamma interferon increases susceptibility to Salmonella enterica serovar Typhimurium-induced pyroptosis in RAW 264.7 cells. Infect. Immun. 76 (2008), 2304–2315.
129. [129] Shenoy, A.R., Wellington, D.A., Kumar, P., Kassa, H., Booth, C.J., Cresswell, P., et al. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 336 (2012), 481–485.
130. [130] Man, S.M., Karki, R., Malireddi, R.K., Neale, G., Vogel, P., Yamamoto, M., et al. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat. Immunol., 2015.
131. [131] Meunier, E., Dick, M.S., Dreier, R.F., Schurmann, N., Kenzelmann Broz, D., Warming, S., et al. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature 509 (2014), 366–370.
132. [132] Nguyen, T.T., Hu, Y., Widney, D.P., Mar, R.A., Smith, J.B., Murine GBP-5, a new member of the murine guanylate-binding protein family, is coordinately regulated with other GBPs in vivo and in vitro. J. Interf. Cytokine Res. 22 (2002), 899–909.
133. [133] Staeheli, P., Prochazka, M., Steigmeier, P.A., Haller, O., Genetic control of interferon action: mouse strain distribution and inheritance of an induced protein with guanylate-binding property. Virology 137 (1984), 135–142.
134. [134] Finethy, R., Jorgensen, I., Haldar, A.K., de Zoete, M.R., Strowig, T., Flavell, R.A., et al. Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages. Infect. Immun., 2015.
135. [135] Meunier, E., Wallet, P., Dreier, R.F., Costanzo, S., Anton, L., Ruhl, S., et al. Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida. Nat. Immunol., 2015.
136. [136] Pilla, D.M., Hagar, J.A., Haldar, A.K., Mason, A.K., Degrandi, D., Pfeffer, K., et al. Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 6046–6051.
137. [137] Elde, N.C., Child, S.J., Geballe, A.P., Malik, H.S., Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457 (2009), 485–489.
138. [138] Sawyer, S.L., Wu, L.I., Emerman, M., Malik, H.S., Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 2832–2837.
139. [139] Barber, M.F., Elde, N.C., Nutritional immunity. Escape from bacterial iron piracy through rapid evolution of transferrin. Science 346 (2014), 1362–1366.
140. [140] Mitchell, P.S., Patzina, C., Emerman, M., Haller, O., Malik, H.S., Kochs, G., Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA. Cell Host Microbe 12 (2012), 598–604.
141. [141] Vernot, B., Tucci, S., Kelso, J., Schraiber, J.G., Wolf, A.B., Gittelman, R.M., et al. Excavating neandertal and denisovan DNA from the genomes of Melanesian individuals. Science, 2016.